Literature DB >> 20364339

Staging in neuropsychiatry: a heuristic model for understanding, prevention and treatment.

Patrick D McGorry1.   

Abstract

The main mental disorders which develop and persist through adult life typically emerge during the critical developmental phase of adolescence and early adulthood, and are frequently associated with considerable associated distress and functional decline. Our current diagnostic system lacks validity and therapeutic utility, particularly for the early stages of these mental disorders, when symptoms are still evolving and may have not yet stabilised sufficiently to fit familiar or traditional syndromal criteria. Furthermore, there is often difficulty in distinguishing transient developmental or normative changes from the early symptoms of persistent and disabling mental illness. These factors point to the need for reform of our current diagnostic systems. The clinical staging model seeks to define the extent of progression of a disorder at a particular point in time and aims to differentiate early, milder clinical phenomena from those that accompany illness progression and chronicity. The staging framework allows clinicians to select treatments relevant to earlier stages of an illness, and to evaluate their effectiveness in preventing progression and producing remission or return to milder or earlier stages of disorder. For staging to be a valid approach, interventions in the early stages need to shown to be not only more effective but also safer than treatments delivered later in the course of illness. Staging may also allow a more efficient integration of our rapidly expanding knowledge of the biological, social and psychological vulnerability factors involved in development of mental illness into what may ultimately resemble a clinicopathological staging model.

Entities:  

Mesh:

Year:  2010        PMID: 20364339     DOI: 10.1007/s12640-010-9179-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  99 in total

1.  Early detection strategies for untreated first-episode psychosis.

Authors:  J O Johannessen; T H McGlashan; T K Larsen; M Horneland; I Joa; S Mardal; R Kvebaek; S Friis; I Melle; S Opjordsmoen; E Simonsen; H Ulrik; P Vaglum
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

2.  Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.

Authors:  Anthony P Morrison; Paul French; Sophie Parker; Morwenna Roberts; Helen Stevens; Richard P Bentall; Shôn W Lewis
Journal:  Schizophr Bull       Date:  2006-09-14       Impact factor: 9.306

Review 3.  Prevention and early intervention for depression in adolescence and early adult life.

Authors:  R Harrington; A Clark
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

4.  Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome.

Authors:  Christoph U Correll; Julie B Penzner; Anne M Frederickson; Jessica J Richter; Andrea M Auther; Christopher W Smith; John M Kane; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2007-05-02       Impact factor: 9.306

Review 5.  Early detection and intervention in the initial prodromal phase of schizophrenia.

Authors:  S Ruhrmann; F Schultze-Lutter; J Klosterkötter
Journal:  Pharmacopsychiatry       Date:  2003-11       Impact factor: 5.788

Review 6.  Early intervention in schizophrenia: current and future perspectives.

Authors:  Matcheri S Keshavan; Ali Amirsadri
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

7.  Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial.

Authors:  Mette Bertelsen; Pia Jeppesen; Lone Petersen; Anne Thorup; Johan Øhlenschlaeger; Phuong le Quach; Torben Østergaard Christensen; Gertrud Krarup; Per Jørgensen; Merete Nordentoft
Journal:  Arch Gen Psychiatry       Date:  2008-07

8.  Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset.

Authors:  W W Eaton; M Badawi; B Melton
Journal:  Am J Psychiatry       Date:  1995-07       Impact factor: 18.112

9.  Early stages in the development of bipolar disorder.

Authors:  Anne Duffy; Martin Alda; Tomas Hajek; Simon B Sherry; Paul Grof
Journal:  J Affect Disord       Date:  2009-06-21       Impact factor: 4.839

10.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01
View more
  7 in total

Review 1.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 2.  Staging and neuroprogression in bipolar disorder.

Authors:  Gabriel Rodrigo Fries; Bianca Pfaffenseller; Laura Stertz; André Vinicius Contri Paz; Aroldo Ayub Dargél; Maurício Kunz; Flávio Kapczinski
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

3.  Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia.

Authors:  Andrea Raballo; Anna Meneghelli; Angelo Cocchi; Davide Sisti; Marco B L Rocchi; Andrea Alpi; Maria T Cascio; Antonio Preti; Kurt Maurer; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-09       Impact factor: 5.270

4.  The Brain Games study: protocol for a randomised controlled trial of computerised cognitive training for preventing mental illness in adolescents with high-risk personality styles.

Authors:  Louise Mewton; Antoinette Hodge; Nicola Gates; Rachel Visontay; Maree Teesson
Journal:  BMJ Open       Date:  2017-09-25       Impact factor: 2.692

Review 5.  The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines.

Authors:  Konstantinos N Fountoulakis; Allan Young; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Pierre Blier; Hans Jurgen Moeller; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 6.  Unmet needs in the management of schizophrenia.

Authors:  Francisco Torres-González; Inmaculada Ibanez-Casas; Sandra Saldivia; Dinarte Ballester; Pamela Grandón; Berta Moreno-Küstner; Miguel Xavier; Manuel Gómez-Beneyto
Journal:  Neuropsychiatr Dis Treat       Date:  2014-01-16       Impact factor: 2.570

7.  Autism spectrum disorders: a meta-analysis of executive function.

Authors:  E A Demetriou; A Lampit; D S Quintana; S L Naismith; Y J C Song; J E Pye; I Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2017-04-25       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.